Our clinical trials program is one of the largest in veterinary oncology and is supported by seven dedicated staff members. Annually, the program manages an average of 30 clinical trials to study more effective therapies for a variety of cancer types including, osteosarcoma, lymphoma, soft tissue sarcoma, and brain tumors. The following trials are currently enrolling patients. For more information, please contact the clinical trials service at (970) 297-4001 or email [email protected].
In general, to participate in one of our clinical trials, patients must be treated at our facility, but will go home after each appointment, unless the protocol dictates otherwise. Most families who participate in our clinical trials live within 150 miles of Fort Collins or are willing to travel or temporarily relocate for the period of the study.
Clinical trials related to pet cancer are conducted throughout the United States. If you do not live close enough to participate in one of our trials, please visit the AVMA Veterinary Clinical Trials Registry website to search for trials in your area.
SOCH (Scout Out Hemangiosarcoma) Study
Clinical Study for B-Cell Lymphoma in Dogs
COTC 031: Safety Evaluation of 3 Forms of an Anti-CTLA-4 Monoclonal Antibody in Tumor-Bearing Pet Dogs
Observational Study of a Novel Canine Cancer Diet
Cryotherapy for Canine Mast Cell Tumors
Expediated Carboplatin for Treatment of Osteosarcoma in Dogs
Combination Radiation Therapy and Gilvetmab for the Treatment of Mast Cell Tumors in Dogs
Novel Therapy with LSD-1 inhibitor for Cats with Oral Squamous Cell Carcinoma
Pharmacokinetics of Compounded Chlorambucil in Cats with Cancer
Single Dose Plasma Pharmacokinetic Analysis of Targeted Anticancer Agents in Tumor Bearing Dogs
Combination Trametinib and Sapanisertib Clinical Trial Pilot Study for Canine Malignant Neoplasia
COTC033: Repurposing Vaccine Immunity to Treat Cancers: Validation in Canine Patients
COTC027: Preclinical Comparison of Two Hypomethylating Nucleosides in Tumor-Bearing Dogs
Combination Therapy with Gilvetmab and Toceranib in Dogs with Mast Cell Tumors
Lattice Radiation Therapy’s Effect on the Immune Response in Canine Sinonasal Carcinoma
Oral Melanoma Study in Dogs
The Evaluation of Adaptation Time in Dogs Undergoing Limb Amputation
One Cure for pets and people with cancer
Funding for our clinical trials program comes from generous donors to our One Cure initiative. One Cure’s founding principle is that cancer affects all creatures, and that treatment breakthroughs come through collaboration between scientists and doctors who are working with both pets and people. One Cure’s goal is to raise awareness and monetary support for clinical trials and comparative oncology research.
Your gift supports the search for better treatment options for pets and people with cancer.